GGrantIndex
Sort

64,565 grants matching drug discovery

Metabolic determinants of Mtb virulence, vulnerability and variation

$2,327,403
David Branch Moody · Brigham And Women'S Hospital · U19 · FY2025 · AI

Expression Genetics in Drug Therapy

$2,327,001
Wolfgang Sadee · Ohio State University · U01 · FY2010 · GM

Open Drug Discovery Center for Alzheimer's Disease

$2,326,786
Allan I Levey · Emory University · U54 · FY2022 · AG

Chemical Approaches to Modulate PAX3-FOXO1 in Fusion-Positive Alveolar Rhabdomyosarcoma

$2,326,552
Angela Nicole Koehler · Massachusetts Institute Of Technology · UM1 · FY2024 · CA

Utah Trial Innovation Center

$2,325,714
Jonathan Michael Dean · University Of Utah · U24 · FY2022 · TR

DNA Replication, Repair, and Mutagenesis In Eukaryotic And Prokaryotic Cells

$2,325,386
Roger Woodgate · Eunice Kennedy Shriver National Institute Of Child Health & Human Development · ZIA · FY2023 · HD

Case GI SPORE

$2,325,000
Sanford D Markowitz · Case Western Reserve University · P50 · FY2019 · CA

Case GI SPORE

$2,324,999
Sanford D Markowitz · Case Western Reserve University · P50 · FY2021 · CA

Nanosystems Biology Cancer Center

$2,324,988
James R. Heath · California Institute Of Technology · U54 · FY2015 · CA

Rewiring of the human protein homeostasis network in normal and disease contexts

$2,324,850
Martin Kampmann · University Of California, San Francisco · DP2 · FY2015 · GM

Development of Novel Therapeutic Strategies in Human Leukemias

$2,324,734
James D Griffin · Dana-Farber Cancer Inst · P01 · FY2012 · CA

SPORE in Skin Cancer

$2,323,912
Meenhard Herlyn · Wistar Institute · P50 · FY2021 · CA

Glycogen synthase kinase 3 ligand discovery for Alzheimer’s disease

$2,323,421
Steven H Liang · Emory University · RF1 · FY2023 · AG

Systems Biology Approach to Redefine Susceptibility Testing and Treatment of MDR Pathogens in the Context of Host Immunity

$2,322,437
Bernhard O Palsson · University Of California, San Diego · U01 · FY2017 · AI

Open Drug Discovery Center for Alzheimer's Disease

$2,321,263
Allan I Levey · Emory University · U54 · FY2019 · AG

Open Drug Discovery Center for Alzheimer's Disease

$2,319,766
Allan I Levey · Emory University · U54 · FY2023 · AG

Nextgen AD Models, Endotypes, and Screening

$2,319,456
Shankar Subramaniam · University Of California, San Diego · RF1 · FY2024 · AG

Cancer Center Support Grant

$2,318,695
Michael A Friedman · Beckman Research Institute/City Of Hope · P30 · FY2010 · CA

Nucleic Acid-Based Nanoconstructs for the Treatment of Cancer

$2,318,682
Chad A. Mirkin · Northwestern University At Chicago · U54 · FY2017 · CA

Mayo Clinic Breast Cancer SPORE

$2,318,378
Matthew Philip Goetz · Mayo Clinic Rochester · P50 · FY2020 · CA

Discovery of novel Henipavirus inhibitors

$2,317,735
Thomas William Geisbert · University Of Texas Med Br Galveston · U19 · FY2023 · AI

Mayo Clinic Breast Cancer SPORE

$2,317,281
Matthew Philip Goetz · Mayo Clinic Rochester · P50 · FY2022 · CA

Cell Migration in 3D microenvironments

$2,315,316
Clare Michal Waterman · National Heart, Lung, And Blood Institute · ZIA · FY2022 · HL

Mayo Clinic Breast Cancer SPORE

$2,314,870
Matthew Philip Goetz · Mayo Clinic Rochester · P50 · FY2024 · CA

Strengthening the ISMMS research and response capabilities for pathogens of pandemic potential

$2,314,456
Randy A. Albrecht · Icahn School Of Medicine At Mount Sinai · G20 · FY2022 · AI